These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
512 related articles for article (PubMed ID: 9920023)
1. Relationship of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover: analyses of synovial fluid from patients with osteoarthritis. Ishiguro N; Ito T; Ito H; Iwata H; Jugessur H; Ionescu M; Poole AR Arthritis Rheum; 1999 Jan; 42(1):129-36. PubMed ID: 9920023 [TBL] [Abstract][Full Text] [Related]
2. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation. Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270 [TBL] [Abstract][Full Text] [Related]
3. Synovial fluid cartilage metabolism marker concentrations in osteonecrosis of the femoral head compared with osteoarthrosis of the hip. Iwase T; Hasegawa Y; Ishiguro N; Ito T; Iwasada S; Kitamura S; Iwata H J Rheumatol; 1998 Mar; 25(3):527-31. PubMed ID: 9517775 [TBL] [Abstract][Full Text] [Related]
4. Relationships of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover and inflammation as revealed by analyses of synovial fluids from patients with rheumatoid arthritis. Ishiguro N; Ito T; Oguchi T; Kojima T; Iwata H; Ionescu M; Poole AR Arthritis Rheum; 2001 Nov; 44(11):2503-11. PubMed ID: 11710706 [TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis. Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734 [TBL] [Abstract][Full Text] [Related]
6. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1). Dahlberg L; Billinghurst RC; Manner P; Nelson F; Webb G; Ionescu M; Reiner A; Tanzer M; Zukor D; Chen J; van Wart HE; Poole AR Arthritis Rheum; 2000 Mar; 43(3):673-82. PubMed ID: 10728762 [TBL] [Abstract][Full Text] [Related]
7. Changes in joint cartilage aggrecan after knee injury and in osteoarthritis. Lohmander LS; Ionescu M; Jugessur H; Poole AR Arthritis Rheum; 1999 Mar; 42(3):534-44. PubMed ID: 10088777 [TBL] [Abstract][Full Text] [Related]
8. The pathobiology of focal lesion development in aging human articular cartilage and molecular matrix changes characteristic of osteoarthritis. Squires GR; Okouneff S; Ionescu M; Poole AR Arthritis Rheum; 2003 May; 48(5):1261-70. PubMed ID: 12746899 [TBL] [Abstract][Full Text] [Related]
9. Determination of stromelysin-1, 72 and 92 kDa type IV collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-2 in synovial fluid and serum from patients with rheumatoid arthritis. Ishiguro N; Ito T; Obata K; Fujimoto N; Iwata H J Rheumatol; 1996 Sep; 23(9):1599-604. PubMed ID: 8877931 [TBL] [Abstract][Full Text] [Related]
10. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro. Little CB; Flannery CR; Hughes CE; Mort JS; Roughley PJ; Dent C; Caterson B Biochem J; 1999 Nov; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534 [TBL] [Abstract][Full Text] [Related]
11. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis. Manicourt DH; Poilvache P; Van Egeren A; Devogelaer JP; Lenz ME; Thonar EJ Arthritis Rheum; 2000 Feb; 43(2):281-8. PubMed ID: 10693867 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-17F affects cartilage matrix turnover by increasing the expression of collagenases and stromelysin-1 and by decreasing the expression of their inhibitors and extracellular matrix components in chondrocytes. Tanigawa S; Aida Y; Kawato T; Honda K; Nakayama G; Motohashi M; Suzuki N; Ochiai K; Matsumura H; Maeno M Cytokine; 2011 Nov; 56(2):376-86. PubMed ID: 21885294 [TBL] [Abstract][Full Text] [Related]
13. [Effect of various intervention factors on MMP-3 and TIMP-1 level in synovial fluid in knee joints with osteroarthritis]. Xu HT; Chen Y; Chen LK; Li JY; Zhang W; Wu B Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 33(1):47-52. PubMed ID: 18245904 [TBL] [Abstract][Full Text] [Related]
14. Sites of collagenase cleavage and denaturation of type II collagen in aging and osteoarthritic articular cartilage and their relationship to the distribution of matrix metalloproteinase 1 and matrix metalloproteinase 13. Wu W; Billinghurst RC; Pidoux I; Antoniou J; Zukor D; Tanzer M; Poole AR Arthritis Rheum; 2002 Aug; 46(8):2087-94. PubMed ID: 12209513 [TBL] [Abstract][Full Text] [Related]
15. Effects of moving training on histology and biomarkers levels of articular cartilage. Qi C; Changlin H J Surg Res; 2006 Oct; 135(2):352-63. PubMed ID: 16904690 [TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases and inhibitor in knee synovial fluid as cartilage biomarkers in rabbits: the effect of high-intensity jumping exercise. Qi C; Changlin H; Zefeng H J Surg Res; 2007 Jun; 140(1):149-57. PubMed ID: 17397871 [TBL] [Abstract][Full Text] [Related]
17. Correlation between osteoarthritic cartilage damage and levels of proteinases and proteinase inhibitors in synovial fluid from the knee joint. Maiotti M; Monteleone G; Tarantino U; Fasciglione GF; Marini S; Coletta M Arthroscopy; 2000; 16(5):522-6. PubMed ID: 10882449 [TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases in mild and severe temporomandibular joint internal derangement synovial fluid. Srinivas R; Sorsa T; Tjäderhane L; Niemi E; Raustia A; Pernu H; Teronen O; Salo T Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 May; 91(5):517-25. PubMed ID: 11346728 [TBL] [Abstract][Full Text] [Related]
19. Levels of matrix metalloproteinase (MMP)-1 in paired sera and synovial fluids of juvenile idiopathic arthritis patients: relationship to inflammatory activity, MMP-3 and tissue inhibitor of metalloproteinases-1 in a longitudinal study. Peake NJ; Khawaja K; Myers A; Jones D; Cawston TE; Rowan AD; Foster HE Rheumatology (Oxford); 2005 Nov; 44(11):1383-9. PubMed ID: 16049050 [TBL] [Abstract][Full Text] [Related]
20. Significant increases in serum and plasma concentrations of matrix metalloproteinases 3 and 9 in patients with rapidly destructive osteoarthritis of the hip. Masuhara K; Nakai T; Yamaguchi K; Yamasaki S; Sasaguri Y Arthritis Rheum; 2002 Oct; 46(10):2625-31. PubMed ID: 12384920 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]